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Abstract
Background: Today there is much debate about why telemedicine has stalled. Teleradiology is the only
widespread telemedicine application. Other telemedicine applications appear to be promising candidates for
widespread use, but they remain in the early adoption stage. The objective of this debate paper is to achieve a
better understanding of the adoption of telemedicine, to assist those trying to move applications from pilot stage
to routine delivery.
Discussion: We have investigated the reasons why telemedicine has stalled by focusing on two, high-level topics:
1) the process of adoption of telemedicine in comparison with other technologies; and 2) the factors involved in
the widespread adoption of telemedicine. For each topic, we have formulated hypotheses. First, the advantages for
users are the crucial determinant of the speed of adoption of technology in healthcare. Second, the adoption of
telemedicine is similar to that of other health technologies and follows an S-shaped logistic growth curve. Third,
evidence of cost-effectiveness is a necessary but not sufficient condition for the widespread adoption of
telemedicine. Fourth, personal incentives for the health professionals involved in service provision are needed
before the widespread adoption of telemedicine will occur.
Summary: The widespread adoption of telemedicine is a major – and still underdeveloped – challenge that needs
to be strengthened through new research directions. We have formulated four hypotheses, which are all
susceptible to experimental verification. In particular, we believe that data about the adoption of telemedicine
should be collected from applications implemented on a large-scale, to test the assumption that the adoption of
telemedicine follows an S-shaped growth curve. This will lead to a better understanding of the process, which will
in turn accelerate the adoption of new telemedicine applications in future. Research is also required to identify
suitable financial and professional incentives for potential telemedicine users and understand their importance for
widespread adoption.
Background
The sustainability of healthcare systems is a matter for
continuing concern [1]. Telemedicine technologies have
been proven to work, and are considered to be a viable
option [2] in future healthcare delivery, allowing health-
care organisations to provide care in a more economic
and comprehensive way. Thus telemedicine is said to be
ready for wider adoption [2]. However, telemedicine has
a poor record of implementation and a very patchy his-
tory of adoption [3], with a slow, uneven and
fragmented uptake into the ongoing and routine opera-
tions of healthcare [4,5].
Telemedicine became practicable at the end of the
1980s with the availability of low-cost computing and
digital telecommunication (e.g. ISDN). Since its incep-
tion, many telemedicine applications have been tested in
small-scale studies, but most of them have failed to sur-
vive beyond the initial (funded) research phase [6], thus
not becoming embedded as methods of routine health
service delivery.
While successful telemedicine applications certainly
exist, they are generally still run by local telemedicine
champions and funded on an ad hoc basis. Almost no
telemedicine applications have succeeded in reaching
large-scale, enterprise-wide adoption [7]. This failure to
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reach widespread adoption has led to studies of the fac-
tors involved in the success and failure of telemedicine
applications [8-13].
In telemedicine, success is a relative term, not an
absolute attribute. That is, a successful telemedicine
application should produce high quality care at low cost
in comparison with an alternative such as usual care
[14]. Many factors are associated with successful teleme-
dicine applications, including demonstrable savings, ade-
quate financing, acceptance by clinicians, improved
access to healthcare and avoidance of travel for patients
in rural and remote areas. Successful telemedicine appli-
cations must also be sustainable (i.e. they must be
adopted into everyday practice and continue to function
after any pilot funding runs out, possibly with high
activity levels). Fundamentally, a successful application
must be cost-effective.
Widespread implementation of telemedicine applications:
the current picture
Over the years a wide range of telemedicine applications
has been trialled. Several promising applications seem to
be candidates for widespread use in the future, such as
telepsychiatry, teledermatology and remote monitoring
for diabetes, cardiac and respiratory diseases [15-17].
However, they remain in the early adoption stage.
Teleradiology is the only widespread application that
can be considered to have reached full adoption [4]. Tel-
eradiology has become an essential part of the practice
of radiology, with broad implications for care delivery
and the organisation of work [18]. In 2003, for example,
two-thirds of all radiology practices in the US reported
using teleradiology, this representing a significant
increase from 1999 [19].
There are several reasons for the widespread adoption
of teleradiology. First, teleradiology has been demon-
strated to provide acceptable diagnostic accuracy in
remote reporting. Second, notwithstanding the invest-
ments required by the hospitals, teleradiology produces
cost savings [20]. Third, in addition to the benefits for
physicians and hospital administrators, there are also
compelling advantages for patients through avoided tra-
vel and rapidity of reporting. Fourth, healthcare payers
have set specific reimbursements for teleradiology. Fifth,
regulation issues have been addressed (e.g. by the Eur-
opean Society of Radiology) [21]. Finally, teleradiology
can benefit from merging with PACS/RIS, thus allowing
a shift from shared data to shared workflow [22] and
increasing the flexibility of provision, for instance
through the use of out-of-hours services.
Aim of this paper
Because most telemedicine applications are still in the
early adoption stage, telemedicine represents an
immature technology. There is much debate about why
telemedicine has stalled. This is a major – and still
underdeveloped – challenge in the field of telemedicine,
which needs to be strengthened through new research
directions.
The objective of this debate paper is to achieve a bet-
ter understanding of the adoption of telemedicine. In
particular, we investigate the reasons why telemedicine
has stalled by focusing on two high-level topics: 1) the
process of adoption of telemedicine in comparison with
other technologies; and 2) the factors involved in the
widespread adoption of telemedicine. That is, the topics
we have selected are at a high level; clearly there may be
other more detailed matters at lower levels, such as spe-
cific barriers to adoption like the absence of reimburse-
ment. This debate paper does not attempt to provide a
comprehensive and systematic explanation of the adop-
tion of telemedicine. We have made a selection of
important topics and formulated certain hypotheses that
we believe to be relevant for new research. These
hypotheses are all susceptible to experimental verifica-
tion. We also believe that these hypotheses can assist
policy makers and health professionals who are trying to




The term “adoption” refers to the decision of potential
users to make full use of an innovation as the best
course of action available [23]. An innovation is consid-
ered to be fully adopted when the majority of potential
users employ it. Before considering the adoption of tele-
medicine specifically, we discuss the adoption of tech-
nology generally, and the adoption of technology in
healthcare.
Adoption of technology generally
The adoption of technology is the result of a complex
decision-making process. It occurs in a number of stages
[Figure 1]. In the first stage, an individual or an organi-
sation must become acquainted with the technology
under consideration (i.e. unless they know about a tech-
nology, they cannot decide to use it). The second stage
consists in forming a favourable or unfavourable opinion
about the new technology; this is termed persuasion.
Here the individual or the organisation wants to know
the advantages and disadvantages of the technology.
After that, they can decide whether to adopt the tech-
nology, or reject it. There is then an initial adoption
stage, which may be followed by the widespread imple-
mentation of the technology, sometimes termed diffu-
sion. Adoption decisions can be reversed during the
diffusion stage, if for example an individual becomes
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dissatisfied with a technology, or a new or improved
technology becomes available [23].
The rate of adoption is the relative speed with which
the members of a social system adopt a technology
[Additional file 1]. This rate of adoption can be mea-
sured through the cumulative percentage of adopters. In
practice, adoption is often observed to follow an S-
shaped logistic growth curve. In Rogers’ classic work on
the subject [23], five different kinds of users were identi-
fied, based on the time at which they adopted a new
technology: 1) innovators, 2) early adopters, 3) early
majority, 4) late majority, and 5) laggards.
Rogers identified two important research questions
about the process of adoption. The first question is how
the early adopters of a technology differ from the later
adopters. With this knowledge, late adopters might be
identified in advance, and targeted in order to speed up
adoption. The second question is how the perceived
attributes of a technology affect its rate of adoption.
With this knowledge, new technologies could be
designed so that they are adopted rapidly.
The above applies to technology adoption generally.
How much of this applies to the adoption of technology
in healthcare?
Adoption of technology in healthcare
The adoption of different technologies in healthcare was
studied by Russell [24]. She studied the adoption of five
technologies which spread widely into US hospitals after
1950. She obtained data from 1953 to 1974 on the
uptake of: the post-operative recovery room, the inten-
sive care unit, the respiratory therapy department, diag-
nostic radioisotope facilities and electroencephalography.
There were four main findings: 1) the S-shaped logistic
growth curve typically used to describe the process of
adoption of innovations in industry also fitted the adop-
tion of these health technologies in US hospitals; 2) the
rate of adoption was different for the five technologies;
3) the adoption of a technology started earlier and was
faster for larger hospitals; 4) when a technology was
attractive, hospitals were as quick to adopt as heavy
industry.
If the rate of adoption differs between technologies,
what factors mean that one is adopted more quickly
than another? Some information on this point comes
from a study of the adoption of Computed Tomogra-
phy (CT) and Magnetic Resonance Imaging (MRI) over
the first four years of their availability in the US [25].
The data showed that adoption of both CT and MRI
was very rapid; indeed it was so fast that manufac-
turers were unable to meet the demand initially. This
was almost certainly due to the substantial improve-
ment in diagnostic capability and safety compared to
existing imaging technologies (i.e. there were major
relative advantages of the new imaging techniques in
comparison with the technologies available at the
time).
However, the rate of adoption of MRI was slower than
that of CT. Since MRI became available about a decade
after CT, that seems surprising. Why was MRI adopted
more slowly? First, MRI did not show an overwhelming
relative advantage compared to existing methods of ima-
ging (which by then included CT) at the time it was
introduced. Second, MRI was subject to substantial
uncertainty due to the technological novelty of the inno-
vation. Third, both technologies were expensive, but the
cost of MRI was much higher than the cost of CT.
Fourth, governmental regulation was introduced to slow
down the adoption of MRI by hospitals [25]. It appears
therefore that the adoption of CT and MRI was driven
by user demand, and that CT was adopted more quickly
due to its major relative advantage.
Governmental regulation may be a factor in adoption,
but it appears that it is only a minor factor. This can be
seen from a study of the adoption of the automated bio-
chemistry analyzer and the CT scanner among hospitals
in New York State [26]. Data for both diagnostic tech-
nologies showed that the adoption patterns fitted an S-
shaped logistic growth curve. However, the rate of adop-
tion of CT was much higher than that of the automated
analyzer. Although CT was more expensive and sub-
jected to more regulation, its adoption was much faster
than that of the automated analyzer, which was an unre-
gulated and low-cost technology. We therefore conclude
that technological adoption is only weakly influenced by
regulatory obstacles. We believe that the crucial deter-
minant of the speed of adoption are the advantages for
users.
H: Advantages for users are the crucial determinant of
the speed of adoption of technology in healthcare.
Figure 1 Stages in the adoption of technology.
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Adoption of telemedicine
In the telemedicine literature there is very little quanti-
tative information about the adoption of telemedicine as
a method of routine delivery. Examples include the
North American telemedicine activities from 1994 to
1999 [27], the email telemedicine network operated by
the Swinfen Charitable Trust over the first six years of
operation [28], the telemedicine services provided by the
Veterans Health Administration in the US [29,30], the
telemedicine practice implemented in US prison systems
[31], and the teleconsultations administered by the US
Department of Defense [32]. However, the value of
these telemedicine initiatives is limited to specific orga-
nisational settings [29] and it is hard to know how wide-
spread is their use within the organisations concerned,
and to draw conclusions about widespread adoption in
other public and private healthcare systems. In this
respect telemedicine can be considered as a “fact-free
zone”. As a consequence, we do not know whether tele-
medicine follows an S-shaped logistic growth curve like
other health technologies.
Some interesting data come from a telemonitoring
service for patients with chronic heart failure (CHF),
which has been widely implemented in the Lombardy
Region of Italy, starting in 2006. It is currently in rou-
tine use. The implementation of this service was regu-
lated by policy makers, who introduced an experimental
regional reimbursement and approved a clinical protocol
[33]. This service was offered to all the hospitals in the
Region, which could decide to apply for authorization
and therefore adopt it on a voluntary basis. The circum-
stances of adoption are therefore similar to the previous
examples concerning CT and MRI in the US. Data were
systematically collected from the first introduction of
the service. In total, 33 hospitals in the Region used the
service over the following four years, starting at different
times. Figure 2 shows the growth in the number of ser-
vice adopters, which seems to follow the S-shaped logis-
tic growth curve typical of health technologies and other
innovations.
Thus according to the limited data available, an
assumption can be made regarding the similarity
between the adoption of telemedicine and that of health
technologies generally.
H: The adoption of telemedicine is similar to that of
other health technologies and follows an S-shaped logistic
growth curve.
Factors in the widespread adoption of telemedicine
The actual adoption of telemedicine is often less than
anticipated [34]. Why is this? Innovation theory outlines
five attributes that influence the rate of adoption of
technologies: 1) relative advantage, 2) compatibility, 3)
trialability, 4) observability, and 5) complexity. Relative
advantage represents the degree to which a technology
is perceived to be better than the existing alternatives
[23]. Research shows that relative advantage is the most
important factor for the adoption of technology [35,36].
Figure 2 Adopters of a telemonitoring service for patients with CHF.
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The example above of CT and MRI confirms that a
compelling relative advantage leads to rapid adoption.
Predictors of telemedicine adoption
Perhaps because of the general absence of quantitative
data about the adoption of telemedicine, the existence
of factors that predict its adoption has been tested
mainly through qualitative studies. Various theoretical
models have been used. These were originally developed
in related fields [37]. For example, the Technology
Acceptance Model (TAM) aims to explain user accep-
tance and to predict the adoption of technologies [38].
In particular, two factors – Perceived Ease of Use and
Perceived Usefulness – have been identified as impor-
tant predictors of adoption by users. The TAM has
been applied to explain physicians’ decisions to accept
telemedicine. In a study conducted in public tertiary
hospitals in Hong Kong, the TAM provided a reasonable
depiction of physicians’ intentions to use telemedicine
[39].
Other theoretical models have been used to investigate
additional factors that might influence the adoption of
telemedicine [40], including the Theory of Planned
Behaviour (TPB) and the Theory of Interpersonal Beha-
viour (TIB) [41]. More recently, May and colleagues
developed a Normalization Process Theory (NPT) to
explain the implementation, embedding and integration
of complex health interventions into everyday practice
[42]. In the case of telemedicine, qualitative data col-
lected through observation and interviews suggested a
number of requirements for its successful adoption.
These include: 1) a positive link with a policy level
sponsor, 2) successful structural integration, 3) cohesive,
cooperative groups, and 4) integration at the level of
professional knowledge and practice [43].
Scholars have also focused on several barriers that
should be addressed for telemedicine adoption to occur.
Reimbursement and legal/regulatory issues are claimed
to be the most common barriers explaining the diffusion
trends for many telemedicine applications [44]. Whitten
and Mackert have pointed out that the provider is the
most important initial gatekeeper for the deployment of
telemedicine, and that project managers must keep pro-
viders’ needs (ease of use and incentives) in mind when
designing a telemedicine system [45]. Other barriers
include technology integration, interoperability, standar-
dization, security, lack of time and financing available
[46].
Evidence in telemedicine – advantages to society
One factor affecting the widespread adoption of teleme-
dicine can be assumed: the evidence that it is a cost-
effective method of practice. Without information on
the costs and effectiveness of interventions, decision
makers – and thus adopters – run the risk of introdu-
cing services that are not cost-effective for society [47].
Information about a technology allows the uncertainty
about its adoption to be reduced. From a societal per-
spective, this is an ethical matter, since resources
expended on an ineffective service are not available for
other, demonstrably effective alternatives.
Systematic reviews have identified evidence for the
advantages of telemedicine to society [48,15]. However
there are still significant gaps in the evidence base
between where telemedicine is used and where its use is
supported by high-quality evidence [49]. In a recent sys-
tematic review of reviews [17], 21 out of 80 heteroge-
neous reviews concluded that telemedicine was effective.
A recent Cochrane systematic literature review con-
cluded that there is clear evidence of the clinical benefits
of telemonitoring for patients with CHF, while more evi-
dence is still required on the cost-effectiveness [50].
It has been claimed that there is no good evidence
that telemedicine is a cost-effective means of delivering
healthcare [51]. However, there has recently been a con-
siderable increase in economic evaluations in telemedi-
cine [52]. Although few economic evaluations of
telemedicine provide reliable information for decision
making [53], there is evidence of the cost-effectiveness
in certain telemedicine services [54], and decisions can
be made on the basis of limited – but sufficiently
detailed – studies [47].
Evidence is regarded as a requirement for the intro-
duction of a new drug or treatment. Similarly, evidence
is needed to evaluate the advantages of telemedicine
applications to society and to convince professionals and
policy makers about implementation [55]. Although
there is evidence of the cost-effectiveness of telemedi-
cine in certain situations, its widespread adoption has
not occurred. The main implication is that evidence of
cost-effectiveness is a necessary but not sufficient condi-
tion for adoption.
H: Evidence of cost-effectiveness is a necessary but not
sufficient condition for the widespread adoption of
telemedicine.
Personal incentives in telemedicine – advantages to
health professionals
One way of viewing the strict evidence of the cost-effec-
tiveness of telemedicine is to regard this as representing
an advantage to society as a whole. However, this is not
the same as the advantage to the individual user (e.g.
doctor or nurse) who makes a decision to employ tele-
medicine when managing a patient.
Here it is worth distinguishing between the decision to
make telemedicine possible in a healthcare system (i.e.
to provide the equipment for doing it) and the decision
to employ it in practice. While the first is usually a
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decision at organisational or governmental level, the lat-
ter is normally made by individual health professionals.
The example of telemedicine in Malaysia is relevant
here, one of the few countries with specific legislation
and guidelines for telemedicine [56]. The Malaysian gov-
ernment studied the evidence for telemedicine from
other parts of the world and attempted to implement it
across the national healthcare system. Despite an invest-
ment of US$5.5 million in a national telemedicine sys-
tem, health professionals handled only a few hundred
cases before the project was withdrawn for re-planning
[57]. As the history of telemedicine so clearly shows,
governments can provide the technology for telemedi-
cine, but unless health professionals are persuaded, the
equipment will not be used.
In a study comparing adopters and non-adopters of tele-
medicine, the number of telemedicine referrals made by
adopters was significantly correlated with adopters’ percep-
tions of the advantages [58]. Health professionals’ percep-
tions, together with organisational and cultural structures
affecting health, legal issues, technical difficulties, time,
convenience, cost, training and familiarity with the equip-
ment, have been claimed to be facilitators for the adoption
of telemedicine [34]. In another study, some differences in
attitudes to telemedicine were found between users and
non-users. In particular, health professionals who used tel-
emedicine in their work had more positive attitudes
towards it [59]. An extensive search of the telemedicine lit-
erature claimed that telemedicine is successful, and there-
fore adopted into routine practice, when it is perceived as a
benefit and as a solution to political and medical issues
[10]. Moreover, different parties in telemedicine are likely
to have very different perspectives, which may influence
their decisions about adoption. For example, health profes-
sionals at remote sites frequently view telemedicine as hav-
ing a relative advantage, while those at hub sites often view
it as offering no relative advantage and requiring changes
to their existing practices and roles [34].
Thus a crucial factor in the adoption of telemedicine
is the attitude of the health professionals on the ground.
Since most telemedicine applications require additional
effort and technical expertise, the use of telemedicine is
almost always more time and trouble than practising in
the ordinary way. We believe that before health profes-
sionals will seriously consider the use of telemedicine,
there must be some personal advantage to the user, in
addition to the general advantages to society.
H: Personal incentives for the health professionals
involved in service provision are needed for the wide-
spread adoption of telemedicine to occur.
What kind of incentives?
The provider is the most important initial gatekeeper for
telemedicine, and therefore incentives should be kept in
mind when implementing telemedicine applications
[45]. What sort of incentives to use telemedicine might
be appropriate? They could include both financial incen-
tives and professional incentives [60].
Financial incentives in healthcare may take the form
of direct payments to health professionals (e.g. fee-for-
service) or indirect payments (e.g. income to spend on
clinical activities, flexibility over a cash-limited budget)
[60]. A systematic review of the impact of financial
incentives for health professionals has shown evidence
that these do affect their behaviour [61]. For example,
there was a positive response from British General
Practitioners (GPs) to financial incentives [62,63].
Moreover, pay for performance policies have been pro-
moted to accelerate improvements in the quality of
care [64,65]. Financial incentives have also been con-
sidered as important factors in helping communicate
the relative advantages of telemedicine to potential
adopters [66], thus motivating health professionals to
use it [16,67,68].
In addition, professional incentives can be employed
in order to influence health professionals. Examples
include status, congeniality of work, career progression,
client differentiation, clinical profile [60] and public
recognition (e.g. report cards) [69,70]. The high initial
physician time costs have sometimes been seen as a
major barrier to adoption of new technologies [71]. Sup-
port for organisational changes to health professionals,
including training, educational material and technical
support, can help them to carry out a time-consuming
workflow more efficiently [72]. Professional incentives
have also been investigated in order to understand why
the adoption of telemedicine remains low. Training,
appropriate personnel [73], support, research ability [16]
and knowledge translation involved in frequent remote
interactions [74] have been claimed to motivate health
professionals to use telemedicine and to speed up its
implementation [16].
Summary
The widespread adoption of telemedicine is a major –
and still underdeveloped – challenge that needs to be
strengthened through new research directions. We have
formulated four hypotheses about telemedicine adop-
tion, which are all susceptible to experimental
verification.
First, advantages for users are the crucial determinant
of the speed of adoption of technology in healthcare.
The rapid growth of two major imaging technologies,
CT and MRI, shows clearly that health technologies are
adopted if users, especially health professionals, want
them (i.e. if they perceive that those technologies sub-
stantially improve the way they can practice). We thus
believe that these considerations should be taken into
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account in future studies addressing the adoption of
telemedicine.
Second, adoption of technology tends to follow an S-
shaped logistic growth curve where the adopters decide
to use a technology at different times. This also applies
to the adoption of new health technologies. We believe
that data about the adoption of telemedicine should be
collected from applications implemented on a large-
scale, to test the assumption that the adoption of tele-
medicine follows an S-shaped growth curve. This will
lead to a better understanding of those who are likely to
adopt new telemedicine applications in future.
Third, before the widespread adoption of a telemedi-
cine application can be justified, formal evidence of the
advantages to society is required. Although there is evi-
dence of the cost-effectiveness of telemedicine in certain
situations, its widespread adoption has not occurred.
We thus believe that the evidence of cost-effectiveness
is a necessary but not sufficient condition for adoption.
Fourth, evidence is crucial to prove the advantages of
telemedicine to society, but advantages to health profes-
sionals in the form of personal incentives are also
needed for the widespread adoption of telemedicine to
occur. Governments can provide health professionals
with the technology, but the majority of potential users
need to perceive compelling relative advantages of tele-
medicine over existing practices in order to adopt it.
We believe that research is also required to identify sui-
table financial and professional incentives for potential
telemedicine users and understand their importance for
widespread adoption.
Additional material
Additional file 1: Rate of adoption. Description of the S-shaped
growth curve characterizing the rate of adoption of technology.
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